Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Lopamudra Das Roy"'
Publikováno v:
Discover Oncology, Vol 13, Iss 1, Pp 1-15 (2022)
Abstract The research focus on CRISPR/Cas9 has gained substantial concentration since the discovery of ‘an unusual repeat sequence’ reported by Ishino et al. (J Bacteriol 169:5429–5433, 1987) and the journey comprises the recent Nobel Prize awa
Externí odkaz:
https://doaj.org/article/4b932a1ccf2f4e689e4a136aa82ac74b
Publikováno v:
Annals of Oncology Research and Therapy, Vol 2, Iss 1, Pp 49-55 (2022)
We report the challenges faced in the villages' Breast Cancer Hub (BCH) adopted in Cachar, Assam, India, since February 2020 during the coronavirus disease 2019 (COVID-19) outbreak. We also present the overall challenges, during COVID-19, even in the
Externí odkaz:
https://doaj.org/article/3d28066f73f94e6096f3dbd390aec714
Autor:
Ru Zhou, Mahboubeh Yazdanifar, Lopamudra Das Roy, Lynsey M. Whilding, Artemis Gavrill, John Maher, Pinku Mukherjee
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Externí odkaz:
https://doaj.org/article/38f6b535cf944d07aec4d1e55175eb60
Autor:
Ru Zhou, Mahboubeh Yazdanifar, Lopamudra Das Roy, Lynsey M. Whilding, Artemis Gavrill, John Maher, Pinku Mukherjee
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Antibody-derived chimeric antigen receptor (CAR) T cell therapy has achieved gratifying breakthrough in hematologic malignancies but has shown limited success in solid tumor immunotherapy. Monoclonal antibody, TAB004, specifically recognizes the aber
Externí odkaz:
https://doaj.org/article/57b677a36b7045db9c944649c0b548c1
Autor:
Jennifer M Curry, Dahlia M Besmer, Timothy K Erick, Nury Steuerwald, Lopamudra Das Roy, Priyanka Grover, Shanti Rao, Sritama Nath, Jacob W Ferrier, Robert W Reid, Pinku Mukherjee
Publikováno v:
PLoS ONE, Vol 14, Iss 11, p e0224309 (2019)
In recent years, vaccines against tumor antigens have shown potential for combating invasive cancers, including primary tumors and metastatic lesions. This is particularly pertinent for breast cancer, which is the second-leading cause of cancer-relat
Externí odkaz:
https://doaj.org/article/15f6f579b4ae4c04ac423dc647dfd330
Autor:
Laura Jeffords Moore, Lopamudra Das Roy, Ru Zhou, Priyanka Grover, Shu-ta Wu, Jennifer M. Curry, Lloye M. Dillon, Priya M. Puri, Mahboubeh Yazdanifar, Rahul Puri, Pinku Mukherjee, Didier Dréau
Publikováno v:
Translational Oncology, Vol 9, Iss 4, Pp 295-305 (2016)
BACKGROUND: Earlier detection of transformed cells using target-specific imaging techniques holds great promise. We have developed TAB 004, a monoclonal antibody highly specific to a protein sequence accessible in the tumor form of MUC1 (tMUC1). We p
Externí odkaz:
https://doaj.org/article/d4fd74fd39b64f049ac6df49895608f7
Myeloid-derived suppressor cells (MDSCs) are immature myeloid cells that are responsible for immunosuppression in tumor microenvironment. Here we report the impact of mucin 1 (MUC1), a transmembrane glycoprotein, on proliferation and functional activ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba3d0e608d8849847906676e5b0b9328
https://doi.org/10.1101/2020.12.07.415299
https://doi.org/10.1101/2020.12.07.415299
Autor:
Mahboubeh Yazdanifar, Lynsey M. Whilding, Pinku Mukherjee, John Maher, Artemis Gavrill, Lopamudra Das Roy, Ru Zhou
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Autor:
Mahboubeh Yazdanifar, Ru Zhou, John Maher, Artemis Gavrill, Lopamudra Das Roy, Pinku Mukherjee, Lynsey M. Whilding
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 10 (2019)
Frontiers in Immunology, Vol 10 (2019)
Antibody-derived chimeric antigen receptor (CAR) T cell therapy has achieved gratifying breakthrough in hematologic malignancies but has shown limited success in solid tumor immunotherapy. Monoclonal antibody, TAB004, specifically recognizes the aber
Autor:
TinChung Leung, Jennifer M. Curry, Jamil Haider, Mahboubeh Yazdanifar, William A. Ahrens, Priyanka Grover, Laura Jeffords Moore, Anishaa Kamesh, Pinku Mukherjee, Ru Zhou, Lopamudra Das Roy, Shu-ta Wu
Publikováno v:
Oncogene
We report that MUC1, a transmembrane glycoprotein that is overexpressed in >80% of pancreatic ductal adenocarcinoma (PDA) induced a pro-angiogenic tumor microenvironment by increasing the levels of neuropilin-1 (NRP1, a co-receptor of VEGF) and its l